ECSP066620A - SUBSTITUTED FUSIONED HETEROCICLIC C-GLYCOSIDES - Google Patents

SUBSTITUTED FUSIONED HETEROCICLIC C-GLYCOSIDES

Info

Publication number
ECSP066620A
ECSP066620A ECSP066620A ECSP066620A EC SP066620 A ECSP066620 A EC SP066620A EC SP066620 A ECSP066620 A EC SP066620A EC SP066620 A ECSP066620 A EC SP066620A
Authority
EC
Ecuador
Prior art keywords
glycosides
substituted
fusioned
heterociclic
prophylaxis
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Maud Urbanski
Original Assignee
Janseen Pharmaceutica N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janseen Pharmaceutica N V filed Critical Janseen Pharmaceutica N V
Publication of ECSP066620A publication Critical patent/ECSP066620A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a C-glicósidos heterocíclicos fusionados y sustituidos, composiciones que los contienen, y métodos para utilizar los mismos, por ejemplo, para el tratamiento o profilaxis de diabetes y síndrome X.This invention relates to fused and substituted heterocyclic C-glycosides, compositions containing them, and methods for using them, for example, for the treatment or prophylaxis of diabetes and syndrome X.

ECSP066620 2003-11-12 2006-06-08 SUBSTITUTED FUSIONED HETEROCICLIC C-GLYCOSIDES ECSP066620A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51921003P 2003-11-12 2003-11-12
US57973004P 2004-06-15 2004-06-15

Publications (1)

Publication Number Publication Date
ECSP066620A true ECSP066620A (en) 2006-10-25

Family

ID=36715445

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP066620 ECSP066620A (en) 2003-11-12 2006-06-08 SUBSTITUTED FUSIONED HETEROCICLIC C-GLYCOSIDES

Country Status (3)

Country Link
EC (1) ECSP066620A (en)
IS (1) IS8445A (en)
RS (1) RS20060321A (en)

Also Published As

Publication number Publication date
RS20060321A (en) 2008-08-07
IS8445A (en) 2006-05-09

Similar Documents

Publication Publication Date Title
EA200601552A1 (en) SUBSTITUTED CONDENSED HETEROCYCLIC C-GLYCOSIDES
CR8402A (en) INDAZOL-O-GLUCOSIDS SUBSTITUTES
EA200601554A1 (en) SUBSTITUTED INDOL-O-GLUCOSIDES
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
WO2005012242A3 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
NI200600094A (en) FUSED HETEROCYCLIC COMPOUND
UY29983A1 (en) DERIVATIVES OF 4-AMINO-PIRROLOTRIAZINE REPLACED USEFUL FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
NO20090313L (en) Derivatives and analogs of N-ethylquinolones and N-ethyllazakinolones
CR9690A (en) 3-ACILAMINOBENZANILIDAS INSECTICIDAS
NO20060202L (en) Pyrrolodihydroisoquinolines as PDE-10 inhibitors
NO20044221L (en) New connections
CR10933A (en) FUNGICIDE BLENDS THAT INCLUDE 1-METHYLPIRAZOL-4-ILCARBOXANILIDS REPLACED
UY29266A1 (en) PIRIDAZINONA COMPOUNDS
GT200600148A (en) METHODS FOR THE TREATMENT AND PREVENTION OF FIBROSIS
ATE346070T1 (en) PURINE DERIVATIVES AS KINASE INHIBITORS
EA200800701A1 (en) 4-substituted pyrrolidin-2-one and their application
UY29458A1 (en) REPLACED HETEROCICLES AND USES OF THE SAME
CR8377A (en) DERIVATIVES OF USEFUL PHENOXYACETIC ACIDS AS DOUBLE RECEIVER AGONISTS ACTIVATED BY PROOFISADOR DE PEROXISOMA
UY29070A1 (en) FUSIONED HETEROCYCLIC ENANTIOMERS AND THEIR USES
BRPI0413973A (en) compounds
DK1664162T3 (en) Polypropylene blown film
CL2007000595A1 (en) Piperidine derived compounds; Pharmaceutical composition and use for the treatment and / or prophylaxis of diseases selected from hypertension, congestive heart failure and renal failure, among others.
BR0307894A (en) Fused tricyclic heterocycles useful for the treatment of hyperproliferative disorders
UY29074A1 (en) SELECTED FUSIONED HETEROCYCLES AND USES OF THE SAME
CL2009000599A1 (en) Compounds derived from substituted 4,5-dihydro-1h-pyrazol (4,3-g) benzothiazole; pharmaceutical composition; Useful for the treatment and prevention of cancer, infections, inflammatory and autoimmune diseases, among others.